Jobs / United States / Glaxosmithkline LLC
Executive Director, Oncology Translational Medicine, Clinical Pharmacology Modeling and Simulation
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Executive Director, Oncology Clinical Pharmacology Modeling and Simulation We have an exciting opportunity at GSK for a highly motivated and experienced Executive Director to join our team supporting the Oncology Clinical Pharmacology Modelling and Simulation (CPMS) department within Oncology Translational Medicine. This role focuses on delivering CPMS excellence to research and development programs, helping to accelerate the development of innovative oncology therapies by ensuring they reach the right patients, at the right dose, and at the right time. Job Purpose The Executive Director, Clinical pharmacology is responsible for strategic contributions to both drug discovery and development projects. Working in collaboration with colleagues in Research, Clinical This position requires an on-site office presence for 2-3 days per week. Key Responsibilities: This role will provide YOU the opportunity to contribute and lead key activities to progress YOUR career, including: • provide advanced technical, therapeutic, and product development support for programs with a focus on the Oncology portfolio. • provide managerial support to CPMS Managers and Directors. Individuals will be accountable to provide individually, or via their direct reports, optimal application of Clinical Pharmacokinetic (PK), Pharmacodynamic (PD), Clinical Pharmacology and Modeling & Simulation (MS) principles towards efficient drug development, risk management, and registration of compounds. • bridging to clinical pharmacology, and modeling/simulation in support of development programs • collaborate to identify and propose initial design for clinical pharmacology studies (e.g., rBA/BE, DDI, special population, human ADME, and TQT etc.) needed to support clinical development plans, risk assessment, and collaborate with research and development teams • input on development of efficient and effective modeling and simulation strategies, including population PK, exposure-response analysis, and physiologically based PK (PBPK) to support clinical trial design, justification of dosing regimen, and provide supportive evidence of efficacy and safety for regulatory submissions • lead and/or contribute to the authoring of relevant sections/modules of regulatory dossier (including INDs, IBs, briefing packages, or other regulatory dossier) • participate in meetings with regulatory authorities, as needed • implement best practices, trends, learnings, etc from internal and external sources to further CPMS contribution to R&D pipeline • influence, define and execute a coordinated scientific and/or technical strategy (18-24 months planning horizon). Demonstrated ability to co-ordinate outputs from several expertise areas to determine strategy. • Identify and develop talent, providing appropriate coaching to ensure future leadership/succession plans for the CPMS organization. • advise team in the analysis of data, including internally or externally contracted PK/PD data analysis and advanced modeling and simulation, from nonclinical studies • develop relationships with external parties and consortia (and stay current on industry trends and practices. • other duties as assigned. Why you? Basic Qualifications: These may include but are not limited to: • PhD biological/pharmaceutical sciences or related discipline with 15+ years of experience in a biotech/life science, pharmaceutical or related industry (an equivalent combination of experience and education may be considered). • Extensive experience in drug development functions (e.g., Nonclinical and Clinical) is required. • A minimum of 15 years of experience managing matrix team, external service providers (worldwide), and consultants is required. • A minimum of 5 years of experience in managing talent/direc